Report Detail

Medical Devices & Consumables Global Intra-Uterine Contraceptive Devices Market Insights and Forecast to 2026

  • RnM4118043
  • |
  • 06 August, 2020
  • |
  • Global
  • |
  • 149 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Intra-Uterine Contraceptive Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intra-Uterine Contraceptive Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Intra-Uterine Contraceptive Devices market is segmented into
Copper IUCD
Hormonal IUCD

Segment by Application, the Intra-Uterine Contraceptive Devices market is segmented into
Hospitals
Gynaecology clinics
Community healthcare

Regional and Country-level Analysis
The Intra-Uterine Contraceptive Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Intra-Uterine Contraceptive Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Intra-Uterine Contraceptive Devices Market Share Analysis

Intra-Uterine Contraceptive Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Intra-Uterine Contraceptive Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Intra-Uterine Contraceptive Devices business, the date to enter into the Intra-Uterine Contraceptive Devices market, Intra-Uterine Contraceptive Devices product introduction, recent developments, etc.
The major vendors covered:
Bayer AG
Teva Pharmaceuticals Industries
Mona Lisa N.V.
DKT International
Egemen International
Melbea AG
Ocon Medical Ltd.
Pregna International Limited
Medical Engineering Corporation SA
SMB Corporation and Meril Life Sciences Pvt. Ltd.
Medu Scientific Ltd, China RH Contraceptives Co., Ltd
Sanghai Jolly Medical Education Co., Ltd
Bernstein Leibhard LLP
Zheijang Daji Medical Instruments, Ltd.
Nimble International
AME Line, Technico
Cepeo
Contraceptivos
Injeflex Ind And Com Ltda
Bersil
Amed


1 Study Coverage

  • 1.1 Intra-Uterine Contraceptive Devices Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Intra-Uterine Contraceptive Devices Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Intra-Uterine Contraceptive Devices Market Size Growth Rate by Type
    • 1.4.2 Copper IUCD
    • 1.4.3 Hormonal IUCD
  • 1.5 Market by Application
    • 1.5.1 Global Intra-Uterine Contraceptive Devices Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Gynaecology clinics
    • 1.5.4 Community healthcare
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Intra-Uterine Contraceptive Devices Market Size, Estimates and Forecasts
    • 2.1.1 Global Intra-Uterine Contraceptive Devices Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Intra-Uterine Contraceptive Devices Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Intra-Uterine Contraceptive Devices Production Estimates and Forecasts 2015-2026
  • 2.2 Global Intra-Uterine Contraceptive Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Intra-Uterine Contraceptive Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Intra-Uterine Contraceptive Devices Manufacturers Geographical Distribution
  • 2.4 Key Trends for Intra-Uterine Contraceptive Devices Markets & Products
  • 2.5 Primary Interviews with Key Intra-Uterine Contraceptive Devices Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Intra-Uterine Contraceptive Devices Manufacturers by Production Capacity
    • 3.1.1 Global Top Intra-Uterine Contraceptive Devices Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Intra-Uterine Contraceptive Devices Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Intra-Uterine Contraceptive Devices Manufacturers Market Share by Production
  • 3.2 Global Top Intra-Uterine Contraceptive Devices Manufacturers by Revenue
    • 3.2.1 Global Top Intra-Uterine Contraceptive Devices Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Intra-Uterine Contraceptive Devices Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Intra-Uterine Contraceptive Devices Revenue in 2019
  • 3.3 Global Intra-Uterine Contraceptive Devices Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Intra-Uterine Contraceptive Devices Production by Regions

  • 4.1 Global Intra-Uterine Contraceptive Devices Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Intra-Uterine Contraceptive Devices Regions by Production (2015-2020)
    • 4.1.2 Global Top Intra-Uterine Contraceptive Devices Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Intra-Uterine Contraceptive Devices Production (2015-2020)
    • 4.2.2 North America Intra-Uterine Contraceptive Devices Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Intra-Uterine Contraceptive Devices Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Intra-Uterine Contraceptive Devices Production (2015-2020)
    • 4.3.2 Europe Intra-Uterine Contraceptive Devices Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Intra-Uterine Contraceptive Devices Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Intra-Uterine Contraceptive Devices Production (2015-2020)
    • 4.4.2 China Intra-Uterine Contraceptive Devices Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Intra-Uterine Contraceptive Devices Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Intra-Uterine Contraceptive Devices Production (2015-2020)
    • 4.5.2 Japan Intra-Uterine Contraceptive Devices Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Intra-Uterine Contraceptive Devices Import & Export (2015-2020)

5 Intra-Uterine Contraceptive Devices Consumption by Region

  • 5.1 Global Top Intra-Uterine Contraceptive Devices Regions by Consumption
    • 5.1.1 Global Top Intra-Uterine Contraceptive Devices Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Intra-Uterine Contraceptive Devices Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Intra-Uterine Contraceptive Devices Consumption by Application
    • 5.2.2 North America Intra-Uterine Contraceptive Devices Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Intra-Uterine Contraceptive Devices Consumption by Application
    • 5.3.2 Europe Intra-Uterine Contraceptive Devices Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Intra-Uterine Contraceptive Devices Consumption by Application
    • 5.4.2 Asia Pacific Intra-Uterine Contraceptive Devices Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Intra-Uterine Contraceptive Devices Consumption by Application
    • 5.5.2 Central & South America Intra-Uterine Contraceptive Devices Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Intra-Uterine Contraceptive Devices Consumption by Application
    • 5.6.2 Middle East and Africa Intra-Uterine Contraceptive Devices Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Intra-Uterine Contraceptive Devices Market Size by Type (2015-2020)
    • 6.1.1 Global Intra-Uterine Contraceptive Devices Production by Type (2015-2020)
    • 6.1.2 Global Intra-Uterine Contraceptive Devices Revenue by Type (2015-2020)
    • 6.1.3 Intra-Uterine Contraceptive Devices Price by Type (2015-2020)
  • 6.2 Global Intra-Uterine Contraceptive Devices Market Forecast by Type (2021-2026)
    • 6.2.1 Global Intra-Uterine Contraceptive Devices Production Forecast by Type (2021-2026)
    • 6.2.2 Global Intra-Uterine Contraceptive Devices Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Intra-Uterine Contraceptive Devices Price Forecast by Type (2021-2026)
  • 6.3 Global Intra-Uterine Contraceptive Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Intra-Uterine Contraceptive Devices Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Intra-Uterine Contraceptive Devices Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Bayer AG
    • 8.1.1 Bayer AG Corporation Information
    • 8.1.2 Bayer AG Overview
    • 8.1.3 Bayer AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Bayer AG Product Description
    • 8.1.5 Bayer AG Related Developments
  • 8.2 Teva Pharmaceuticals Industries
    • 8.2.1 Teva Pharmaceuticals Industries Corporation Information
    • 8.2.2 Teva Pharmaceuticals Industries Overview
    • 8.2.3 Teva Pharmaceuticals Industries Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Teva Pharmaceuticals Industries Product Description
    • 8.2.5 Teva Pharmaceuticals Industries Related Developments
  • 8.3 Mona Lisa N.V.
    • 8.3.1 Mona Lisa N.V. Corporation Information
    • 8.3.2 Mona Lisa N.V. Overview
    • 8.3.3 Mona Lisa N.V. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Mona Lisa N.V. Product Description
    • 8.3.5 Mona Lisa N.V. Related Developments
  • 8.4 DKT International
    • 8.4.1 DKT International Corporation Information
    • 8.4.2 DKT International Overview
    • 8.4.3 DKT International Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 DKT International Product Description
    • 8.4.5 DKT International Related Developments
  • 8.5 Egemen International
    • 8.5.1 Egemen International Corporation Information
    • 8.5.2 Egemen International Overview
    • 8.5.3 Egemen International Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Egemen International Product Description
    • 8.5.5 Egemen International Related Developments
  • 8.6 Melbea AG
    • 8.6.1 Melbea AG Corporation Information
    • 8.6.2 Melbea AG Overview
    • 8.6.3 Melbea AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Melbea AG Product Description
    • 8.6.5 Melbea AG Related Developments
  • 8.7 Ocon Medical Ltd.
    • 8.7.1 Ocon Medical Ltd. Corporation Information
    • 8.7.2 Ocon Medical Ltd. Overview
    • 8.7.3 Ocon Medical Ltd. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Ocon Medical Ltd. Product Description
    • 8.7.5 Ocon Medical Ltd. Related Developments
  • 8.8 Pregna International Limited
    • 8.8.1 Pregna International Limited Corporation Information
    • 8.8.2 Pregna International Limited Overview
    • 8.8.3 Pregna International Limited Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Pregna International Limited Product Description
    • 8.8.5 Pregna International Limited Related Developments
  • 8.9 Medical Engineering Corporation SA
    • 8.9.1 Medical Engineering Corporation SA Corporation Information
    • 8.9.2 Medical Engineering Corporation SA Overview
    • 8.9.3 Medical Engineering Corporation SA Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Medical Engineering Corporation SA Product Description
    • 8.9.5 Medical Engineering Corporation SA Related Developments
  • 8.10 SMB Corporation and Meril Life Sciences Pvt. Ltd.
    • 8.10.1 SMB Corporation and Meril Life Sciences Pvt. Ltd. Corporation Information
    • 8.10.2 SMB Corporation and Meril Life Sciences Pvt. Ltd. Overview
    • 8.10.3 SMB Corporation and Meril Life Sciences Pvt. Ltd. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 SMB Corporation and Meril Life Sciences Pvt. Ltd. Product Description
    • 8.10.5 SMB Corporation and Meril Life Sciences Pvt. Ltd. Related Developments
  • 8.11 Medu Scientific Ltd, China RH Contraceptives Co., Ltd
    • 8.11.1 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Corporation Information
    • 8.11.2 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Overview
    • 8.11.3 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Product Description
    • 8.11.5 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Related Developments
  • 8.12 Sanghai Jolly Medical Education Co., Ltd
    • 8.12.1 Sanghai Jolly Medical Education Co., Ltd Corporation Information
    • 8.12.2 Sanghai Jolly Medical Education Co., Ltd Overview
    • 8.12.3 Sanghai Jolly Medical Education Co., Ltd Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 Sanghai Jolly Medical Education Co., Ltd Product Description
    • 8.12.5 Sanghai Jolly Medical Education Co., Ltd Related Developments
  • 8.13 Bernstein Leibhard LLP
    • 8.13.1 Bernstein Leibhard LLP Corporation Information
    • 8.13.2 Bernstein Leibhard LLP Overview
    • 8.13.3 Bernstein Leibhard LLP Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.13.4 Bernstein Leibhard LLP Product Description
    • 8.13.5 Bernstein Leibhard LLP Related Developments
  • 8.14 Zheijang Daji Medical Instruments, Ltd.
    • 8.14.1 Zheijang Daji Medical Instruments, Ltd. Corporation Information
    • 8.14.2 Zheijang Daji Medical Instruments, Ltd. Overview
    • 8.14.3 Zheijang Daji Medical Instruments, Ltd. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.14.4 Zheijang Daji Medical Instruments, Ltd. Product Description
    • 8.14.5 Zheijang Daji Medical Instruments, Ltd. Related Developments
  • 8.15 Nimble International
    • 8.15.1 Nimble International Corporation Information
    • 8.15.2 Nimble International Overview
    • 8.15.3 Nimble International Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.15.4 Nimble International Product Description
    • 8.15.5 Nimble International Related Developments
  • 8.16 AME Line, Technico
    • 8.16.1 AME Line, Technico Corporation Information
    • 8.16.2 AME Line, Technico Overview
    • 8.16.3 AME Line, Technico Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.16.4 AME Line, Technico Product Description
    • 8.16.5 AME Line, Technico Related Developments
  • 8.17 Cepeo
    • 8.17.1 Cepeo Corporation Information
    • 8.17.2 Cepeo Overview
    • 8.17.3 Cepeo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.17.4 Cepeo Product Description
    • 8.17.5 Cepeo Related Developments
  • 8.18 Contraceptivos
    • 8.18.1 Contraceptivos Corporation Information
    • 8.18.2 Contraceptivos Overview
    • 8.18.3 Contraceptivos Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.18.4 Contraceptivos Product Description
    • 8.18.5 Contraceptivos Related Developments
  • 8.19 Injeflex Ind And Com Ltda
    • 8.19.1 Injeflex Ind And Com Ltda Corporation Information
    • 8.19.2 Injeflex Ind And Com Ltda Overview
    • 8.19.3 Injeflex Ind And Com Ltda Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.19.4 Injeflex Ind And Com Ltda Product Description
    • 8.19.5 Injeflex Ind And Com Ltda Related Developments
  • 8.20 Bersil
    • 8.20.1 Bersil Corporation Information
    • 8.20.2 Bersil Overview
    • 8.20.3 Bersil Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.20.4 Bersil Product Description
    • 8.20.5 Bersil Related Developments
  • 8.21 Amed
    • 8.21.1 Amed Corporation Information
    • 8.21.2 Amed Overview
    • 8.21.3 Amed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.21.4 Amed Product Description
    • 8.21.5 Amed Related Developments

9 Intra-Uterine Contraceptive Devices Production Forecast by Regions

  • 9.1 Global Top Intra-Uterine Contraceptive Devices Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Intra-Uterine Contraceptive Devices Regions Forecast by Production (2021-2026)
  • 9.3 Key Intra-Uterine Contraceptive Devices Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Intra-Uterine Contraceptive Devices Consumption Forecast by Region

  • 10.1 Global Intra-Uterine Contraceptive Devices Consumption Forecast by Region (2021-2026)
  • 10.2 North America Intra-Uterine Contraceptive Devices Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Intra-Uterine Contraceptive Devices Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Intra-Uterine Contraceptive Devices Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Intra-Uterine Contraceptive Devices Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Intra-Uterine Contraceptive Devices Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Intra-Uterine Contraceptive Devices Sales Channels
    • 11.2.2 Intra-Uterine Contraceptive Devices Distributors
  • 11.3 Intra-Uterine Contraceptive Devices Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Intra-Uterine Contraceptive Devices Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 Intra-Uterine Contraceptive Devices Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Intra-Uterine Contraceptive Devices Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on Intra-Uterine Contraceptive Devices. Industry analysis & Market Report on Intra-Uterine Contraceptive Devices is a syndicated market report, published as Global Intra-Uterine Contraceptive Devices Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Intra-Uterine Contraceptive Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,802.40
    5,703.60
    7,604.80
    4,566.80
    6,850.20
    9,133.60
    756,021.00
    1,134,031.50
    1,512,042.00
    413,168.00
    619,752.00
    826,336.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report